Aarey Drugs & Pharmaceuticals Limited
NSE: AAREYDRUGS BSE: AAREYDRUGS
NSE
71.75
-3.79 (-5.02%)
Prev Close
75.54
Open Price
74
Volume
136,348
Today Low / High
70.1 / 76.95
52 WK Low / High
32.85 / 100
Range
68 - 75
BSE
71.40
-3.76 (-5.00%)
Prev Close
75.16
Open Price
74
Volume
5,494
Today Low / High
71 / 77.32
52 WK Low / High
31.3 / 100
Range
68 - 75
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 71.75 (target range: 68 - 75), reflecting a change of -3.79 (-5.01721%). On the BSE, it is listed at 71.4 (target range: 68 - 75), showing a change of -3.76 (-5.00266%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
25 Feb
74.00
-3.04%
24 Feb
79.64
-5.15%
23 Feb
85.99
-6.40%
20 Feb
72.48
8.33%
19 Feb
71.00
0.55%
18 Feb
66.30
7.50%
17 Feb
65.77
2.05%
16 Feb
66.65
-0.35%
13 Feb
69.87
-4.14%
12 Feb
66.75
6.28%
11 Feb
65.66
3.52%
10 Feb
69.50
-6.00%
09 Feb
67.18
3.80%
06 Feb
66.48
1.05%
05 Feb
64.95
1.02%
04 Feb
64.99
-3.40%
03 Feb
64.00
1.48%
02 Feb
64.22
-0.33%
01 Feb
67.00
-4.04%
30 Jan
69.77
-3.11%
29 Jan
70.74
0.58%
28 Jan
69.96
1.11%
Aarey Drugs & Pharmaceuticals Limited Graph
Aarey Drugs & Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aarey Drugs & Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 71.75, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 71.40 | 72.11 | 64.90 - 79.33 |
| 72.83 | 58.26 - 87.39 | ||
| 73.54 | 51.48 - 95.60 | ||
| Bearish Scenario | 71.40 | 70.69 | 63.62 - 77.75 |
| 69.97 | 55.98 - 83.97 | ||
| 69.26 | 48.48 - 90.04 |
Overview of Aarey Drugs & Pharmaceuticals Limited
ISIN
INE198H01019
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
247,397
Market Cap
2,034,421,240
Last Dividend
0
Official Website
IPO Date
2021-08-06
DCF Diff
119.59
DCF
-46
Financial Ratios Every Investor Needs
Stock Dividend of AAREYDRUGS
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2018-12-13 | December 13, 18 | 0.1 | 0.1 | 2018-12-14 | 2018-12-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 473.94 Cr | 464.81 Cr | 9.13 Cr | 0.0193 | 0.00 Cr | 1.34 Cr | 0.31 Cr | 4.02 Cr | 1.43 | 12.06 Cr | 0.0085 |
| 2024-03-31 | 395.10 Cr | 381.90 Cr | 13.20 Cr | 0.0334 | 0.00 Cr | 0.42 Cr | 2.82 Cr | 4.68 Cr | 1.84 | 11.42 Cr | 0.0119 |
| 2023-03-31 | 418.96 Cr | 403.84 Cr | 11.51 Cr | 0.0275 | 0.00 Cr | 0.88 Cr | 13.53 Cr | 3.77 Cr | 1.49 | 10.45 Cr | 0.0090 |
| 2022-03-31 | 491.61 Cr | 472.06 Cr | 19.54 Cr | 0.0398 | 0.00 Cr | 0.61 Cr | 11.77 Cr | 6.55 Cr | 2.72 | 14.06 Cr | 0.0133 |
| 2021-03-31 | 347.89 Cr | 337.79 Cr | 10.10 Cr | 0.0290 | 0.00 Cr | 0.32 Cr | 3.87 Cr | 6.51 Cr | 2.79 | 11.67 Cr | 0.0187 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.47 Cr | 238.27 Cr | 99.79 Cr | 138.4805 Cr | 34.86 Cr | 33.38 Cr | 45.48 Cr | 16.22 Cr | 0.00 Cr | 0.00 Cr | 3.10 Cr | 96.8804 Cr |
| 2024-03-31 | 1.59 Cr | 303.29 Cr | 170.52 Cr | 132.7734 Cr | 31.35 Cr | 29.76 Cr | 71.99 Cr | 12.96 Cr | 0.00 Cr | 0.00 Cr | 2.09 Cr | 166.5469 Cr |
| 2023-03-31 | 0.71 Cr | 291.32 Cr | 173.91 Cr | 117.4138 Cr | 37.72 Cr | 37.01 Cr | 65.18 Cr | 13.94 Cr | 5.28 Cr | 0.00 Cr | 1.19 Cr | 168.1349 Cr |
| 2022-03-31 | 0.19 Cr | 245.17 Cr | 131.53 Cr | 113.6373 Cr | 14.16 Cr | 13.97 Cr | 56.12 Cr | 14.47 Cr | 0.89 Cr | 0.00 Cr | 2.80 Cr | 126.7362 Cr |
| 2021-03-31 | 0.64 Cr | 233.04 Cr | 134.18 Cr | 98.8605 Cr | 18.02 Cr | 17.38 Cr | 46.93 Cr | 14.26 Cr | 0.00 Cr | 0.00 Cr | 0.40 Cr | 130.8039 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.8948 Cr | -5.9394 Cr | 4.9237 Cr | -4.3096 Cr | -0.1211 Cr | 1.4733 Cr | -5.2044 Cr | 4.0239 Cr | 3.2337 Cr | 0.0000 Cr | -10.8045 Cr |
| 2024-03-31 | -2.9938 Cr | -1.7023 Cr | 5.5848 Cr | -3.7161 Cr | 0.8886 Cr | 1.5944 Cr | -0.7223 Cr | 4.6837 Cr | -1.1362 Cr | 0.0000 Cr | -5.8566 Cr |
| 2023-03-31 | -1.2811 Cr | 0.4410 Cr | 1.3540 Cr | -2.3251 Cr | 0.5139 Cr | 0.7058 Cr | -1.0440 Cr | 6.0151 Cr | 4.2211 Cr | 0.0000 Cr | -15.1352 Cr |
| 2022-03-31 | -4.4930 Cr | -2.1967 Cr | 2.2534 Cr | -6.6943 Cr | -0.4578 Cr | 0.1919 Cr | -2.2013 Cr | 10.0271 Cr | -3.9786 Cr | 0.0000 Cr | 4.7767 Cr |
| 2021-03-31 | 5.4770 Cr | -2.8793 Cr | -2.4507 Cr | 2.5977 Cr | 0.1470 Cr | 0.6497 Cr | -2.8793 Cr | 8.3014 Cr | -0.0191 Cr | 0.0000 Cr | -1.4646 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 96.43 Cr | 97.77 Cr | -1.34 Cr | -0.0139 | -2.34 Cr | 0.57 Cr | 0.20 | -1.51 Cr | 0.0059 |
| 2025-09-30 | 84.16 Cr | 81.36 Cr | 2.80 Cr | 0.0333 | 1.95 Cr | 1.02 Cr | 0.36 | 3.44 Cr | 0.0122 |
| 2025-06-30 | 102.21 Cr | 97.84 Cr | 4.37 Cr | 0.0428 | 1.22 Cr | 1.37 Cr | 0.48 | 3.25 Cr | 0.0134 |
| 2025-03-31 | 108.10 Cr | 108.02 Cr | 0.08 Cr | 0.0007 | -3.43 Cr | 0.47 Cr | 0.17 | 2.69 Cr | 0.0043 |
| 2024-12-31 | 133.79 Cr | 130.39 Cr | 3.40 Cr | 0.0254 | 1.62 Cr | 0.72 Cr | 0.26 | 2.88 Cr | 0.0054 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 7.19 Cr | 1.00 Cr | 8.19 Cr | 122.34 Cr | 39.12 Cr | 256.36 Cr | 25.09 Cr | 294.00 Cr | 145.15 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 3.23 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -138.48 Cr |
| 2025-03-31 | 1.47 Cr | 0.00 Cr | 1.47 Cr | 159.55 Cr | 45.48 Cr | 213.28 Cr | 16.22 Cr | 238.27 Cr | 99.79 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1.49 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -135.59 Cr |
| 2024-09-30 | 1.49 Cr | 0.00 Cr | 1.49 Cr | 23.52 Cr | 29.84 Cr | 251.35 Cr | 12.99 Cr | 274.53 Cr | 138.94 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 1.37 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 0.47 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 1.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 1.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,764.20 | ₹4,232,906,754,074.00 | ₹1,200,910.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,395.50 | ₹1,697,804,303,390.00 | ₹348,437.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,418.90 | ₹1,495,556,554,816.00 | ₹359,909.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,306.50 | ₹1,087,750,340,235.00 | ₹2,296,180.00 |
| Lupin Limited | LUPIN | ₹2,292.20 | ₹1,047,633,964,600.00 | ₹1,104,211.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹919.65 | ₹925,383,088,904.00 | ₹564,412.00 |
| Mankind Pharma Limited | MANKIND | ₹2,155.70 | ₹889,883,893,710.00 | ₹802,349.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,211.50 | ₹703,641,166,265.00 | ₹3,039,172.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,625.00 | ₹672,553,125,000.00 | ₹231,439.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,085.00 | ₹588,388,686,765.00 | ₹455,450.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,076.35 | ₹581,074,632,036.00 | ₹2,096,370.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,524.50 | ₹386,772,080,341.00 | ₹102,371.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹3,021.30 | ₹377,468,000,791.00 | ₹185,671.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,085.90 | ₹334,844,408,201.00 | ₹172,351.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,430.80 | ₹271,240,390,232.00 | ₹90,076.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,377.10 | ₹223,767,965,930.00 | ₹212,770.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,869.00 | ₹221,725,000,000.00 | ₹2,566.00 |
| Eris Lifesciences Limited | ERIS | ₹1,380.20 | ₹188,006,552,958.00 | ₹30,161.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹978.20 | ₹175,205,274,834.00 | ₹5,721,405.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,331.00 | ₹171,035,250,259.00 | ₹27,190.00 |
| Granules India Limited | GRANULES | ₹599.95 | ₹145,589,096,164.00 | ₹775,187.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹739.90 | ₹145,437,055,448.00 | ₹143,343.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹897.35 | ₹142,113,093,368.00 | ₹305,229.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,727.00 | ₹131,272,198,992.00 | ₹21,410.00 |
| Cohance Lifesciences Limited | COHANCE | ₹310.50 | ₹118,787,096,970.00 | ₹467,931.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹907.55 | ₹111,389,056,800.00 | ₹41,715.00 |
| Viyash Scientific Limited | VIYASH | ₹219.27 | ₹95,646,792,922.00 | ₹684,479.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,136.00 | ₹85,254,425,952.00 | ₹7,919.00 |
| Strides Pharma Science Limited | STAR | ₹863.60 | ₹79,600,355,810.00 | ₹85,803.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹478.65 | ₹73,282,300,062.00 | ₹136,589.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹708.30 | ₹64,205,475,507.00 | ₹171,833.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹327.45 | ₹64,043,265,649.00 | ₹194,387.00 |
| FDC Limited | FDC | ₹364.30 | ₹59,311,713,601.00 | ₹46,671.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹130.92 | ₹42,486,366,301.00 | ₹619,172.00 |
| Innova Captab Limited | INNOVACAP | ₹668.35 | ₹38,246,281,297.00 | ₹12,022.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹316.30 | ₹34,465,713,320.00 | ₹32,182.00 |
| Suven Life Sciences Limited | SUVEN | ₹149.76 | ₹34,066,506,240.00 | ₹112,567.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹369.70 | ₹33,742,519,000.00 | ₹60,664.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹630.60 | ₹31,983,467,613.00 | ₹129,611.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,914.20 | ₹31,658,982,513.00 | ₹9,690.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹279.30 | ₹28,008,903,926.00 | ₹39,032.00 |
Key Executives
Chief Accountant
A. S. Kathawala
Gender: male
Year Born: 1976
Company Secretary & Compliance Officer
Kailash Chand Jethlia
Gender: male
Year Born:
Chairman & MD
Mihir Rajesh Ghatalia
Gender: male
Year Born: 1983
Executive Director
Nimit Rajesh Ghatalia
Gender: male
Year Born: 1996
Chief Financial Officer
Mira Mihir Ghatalia
Gender: female
Year Born:
FAQs about Aarey Drugs & Pharmaceuticals Limited
Who is the CEO of the company?
The CEO is Mihir Rajesh Ghatalia.
What is the current market price of the stock?
The current price is ₹71.75.
What is the 52-week price range?
The range is ₹32.85-100.
What is the market capitalization of the company?
The market capitalization is ₹203.44 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 59.44.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Aarey Drugs & Pharmaceuticals Limited (ISIN: INE198H01019) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹203.44 crores and an average daily volume of 247,397 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.